ECoG BMI for Motor and Speech Control

Part of paid clinical trials in San Francisco, California.

Sponsor
Karunesh Ganguly
Study ID
NCT03698149
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • PMT/Blackrock Combination Device — DEVICE
    PMT Subdural Cortical Electrodes/Blackrock NeuroPort Array and NeuroPort System

Study Details

Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.

Key Dates

Start date
Nov 9, 2018
Status verified
Apr 2026
Primary completion
Aug 15, 2030
Completion
Aug 15, 2030

Study Design

Enrollment
3 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY

Arms

  • Experimental: Electrocorticography-based brain computer interface

Primary Outcome Measure

Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] [ Time Frame: Up to 6 years post-implant period ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California San FranciscoSan FranciscoCalifornia94158
Adelyn Tu-Chan
[email protected]
(415) 575-0431

Find similar trials in San Francisco, CA

By condition
Multiple sclerosisStroke
By specialty
NeurologyBrain disordersAutoimmune disease
By research site
University of California San Francisco· San Francisco, CA

Related Studies